Roivant Sciences
Development and commercialization of medicines
Roivant Sciences has raised €1.1B across 2 funding rounds from 1 investor, most recently a round in Nov 2018. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandroivant.com ↗
Total raised
€1.1B
€1,115,147,602
Funding rounds
2
Investors
1
distinct backers
Active since
2017-08
latest 2018-11
Funding by year
EUR raised per yearRoivant Sciences — funding by year — interactive chart.
Data table
| Roivant Sciences — funding by year | |
|---|---|
| 2017 | €938M |
| 2018 | €178M |
Signals
Medium confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-11-13 | Other | €178M | — | View deal → |
| 2017-08-11 | Growth/Late | €938M | SoftBank | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
- Energy Vault€898MSwitzerland · Energy
Global coverage: FundingData